Patents by Inventor David F. Stodjl

David F. Stodjl has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8282917
    Abstract: The present invention provides mutant viruses with a decreased ability to block nuclear transport of mRNA or protein in an infected cell which are attenuated in vivo. The mutant viruses of the present invention may also be capable of triggering the anti-viral systems of normal host cells while remaining sensitive to the effects of these systems. The present invention further provides for the use of the mutant viruses in a range of applications including, but not limited to, as therapeutics for the treatment of cancer and infections, as vaccines and adjuvants, as viral vectors, and as oncolytic and cytolytic agents for the selective lysis of malignant or infected cells.
    Type: Grant
    Filed: March 30, 2010
    Date of Patent: October 9, 2012
    Assignees: Wellstat Biologics Corporation, Ottawa Hospital Research Institute
    Inventors: John C. Bell, Brian D. Lichty, David F. Stodjl